• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢噻肟和去乙酰头孢噻肟在新生儿体内的药代动力学

Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates.

作者信息

Crooks J, White L O, Burville L J, Speidel B D, Reeves D S

出版信息

J Antimicrob Chemother. 1984 Sep;14 Suppl B:97-101. doi: 10.1093/jac/14.suppl_b.97.

DOI:10.1093/jac/14.suppl_b.97
PMID:6094467
Abstract

Cefotaxime was given to neonates as treatment of infection in a dose of 25 mg/kg 12 hourly by intravenous injection. Blood samples taken by heel-prick were specially treated to minimize any effect of haemolysis on the hydrolysis of cefotaxime. The mean peak plasma concentrations of cefotaxime on the first, second and third days of therapy were 43, 40 and 52 mg/l, respectively, with mean plasma half lives of 4.0, 2.7 and 3.2 h. The mean peak concentrations of desacetyl-cefotaxime were about a quarter of those of cefotaxime, which is in good agreement with adult studies, but much lower than those previously published in studies with neonates. These results emphasize the care that is necessary in the assay of body fluids and tissues for cefotaxime and desacetyl-cefotaxime if accurate results are to be obtained.

摘要

头孢噻肟以25毫克/千克的剂量,每12小时静脉注射一次,用于治疗新生儿感染。通过足跟采血采集的血样经过特殊处理,以尽量减少溶血对头孢噻肟水解的任何影响。治疗第一天、第二天和第三天头孢噻肟的平均血浆峰值浓度分别为43毫克/升、40毫克/升和52毫克/升,平均血浆半衰期分别为4.0小时、2.7小时和3.2小时。去乙酰头孢噻肟的平均峰值浓度约为头孢噻肟的四分之一,这与成人研究结果相符,但远低于之前新生儿研究中公布的浓度。这些结果强调,如果要获得准确结果,在检测体液和组织中的头孢噻肟和去乙酰头孢噻肟时必须格外小心。

相似文献

1
Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates.头孢噻肟和去乙酰头孢噻肟在新生儿体内的药代动力学
J Antimicrob Chemother. 1984 Sep;14 Suppl B:97-101. doi: 10.1093/jac/14.suppl_b.97.
2
[Studies on the pharmacokinetics of cefotaxime in neonates].[头孢噻肟在新生儿中的药代动力学研究]
Jpn J Antibiot. 1982 Jul;35(7):1793-800.
3
Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.头孢噻肟和去乙酰头孢噻肟在肝硬化患者中的药代动力学
Chemotherapy. 1984;30(1):7-17. doi: 10.1159/000238238.
4
Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.肾功能不全患者及血液透析期间头孢噻肟和去乙酰头孢噻肟的消除动力学
Chemotherapy. 1983;29(1):4-12. doi: 10.1159/000238166.
5
The action of beta-lactamases on desacetyl-cefotaxime and cefotaxime.β-内酰胺酶对去乙酰头孢噻肟和头孢噻肟的作用。
J Antimicrob Chemother. 1984 Sep;14 Suppl B:45-51. doi: 10.1093/jac/14.suppl_b.45.
6
Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.头孢曲松的药代动力学及其与血管外腔室浓度的关系。与头孢噻肟的比较。
Chemotherapy. 1985;31(2):85-94. doi: 10.1159/000238319.
7
Pharmacokinetics of cefotaxime in neonates.
J Antimicrob Chemother. 1984 May;13(5):471-7. doi: 10.1093/jac/13.5.471.
8
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Clin Pharmacol Ther. 1985 Jul;38(1):31-6. doi: 10.1038/clpt.1985.130.
9
Pharmacokinetics of cefotaxime in the postpartum patient.头孢噻肟在产后患者中的药代动力学
Am J Perinatol. 1985 Apr;2(2):114-7. doi: 10.1055/s-2007-999926.
10
The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.头孢噻肟及其代谢产物的人体药代动力学以及肾小管分泌在其消除过程中的作用。
J Pharmacokinet Biopharm. 1985 Apr;13(2):121-42. doi: 10.1007/BF01059394.

引用本文的文献

1
Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.新生儿期青霉素类、头孢菌素类和氨基糖苷类药物的临床药代动力学:综述
Pharmaceuticals (Basel). 2010 Aug 12;3(8):2568-2591. doi: 10.3390/ph3082568.
2
A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.一项评估和优化新生儿及小婴儿头孢噻肟给药方案的群体和发育药代动力学分析。
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6626-6634. doi: 10.1128/AAC.01045-16. Print 2016 Nov.
3
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
新生儿和婴儿最常用的抗菌药、抗真菌药和抗病毒药的药代动力学和药效学
Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0.
4
Pharmacokinetics of cephalosporins in the neonate: a review.头孢菌素类药物在新生儿中的药代动力学:综述。
Clinics (Sao Paulo). 2011;66(7):1267-74. doi: 10.1590/s1807-59322011000700024.
5
Cefotaxime pharmacokinetics and treatment of meningitis in neonates.头孢噻肟在新生儿中的药代动力学及脑膜炎治疗
Infection. 1989 Sep-Oct;17(5):338-42. doi: 10.1007/BF01650725.
6
Clinical pharmacokinetics of antibacterial drugs in neonates.抗菌药物在新生儿中的临床药代动力学。
Clin Pharmacokinet. 1990 Oct;19(4):280-318. doi: 10.2165/00003088-199019040-00003.
7
Cefotaxime. An update of its pharmacology and therapeutic use.头孢噻肟。其药理学与治疗应用的最新进展。
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.
8
Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
Clin Pharmacokinet. 1992 Apr;22(4):284-97. doi: 10.2165/00003088-199222040-00004.